Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.
作者信息
Hagan Holly, Latka Mary H, Campbell Jennifer V, Golub Elizabeth T, Garfein Richard S, Thomas David A, Kapadia Farzana, Strathdee Steffanie A
机构信息
National Development and Research Institutes, Center for Drug Use and HIV Research, New York, NY, 10010, USA.
出版信息
Clin Infect Dis. 2006 Mar 1;42(5):669-72. doi: 10.1086/499951. Epub 2006 Jan 20.
DOI:10.1086/499951
PMID:16447112
Abstract
Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.
摘要
Zotero 插件